Literature DB >> 7519452

Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial.

J M Wilson1, J F Engelhardt, M Grossman, R H Simon, Y Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7519452     DOI： 10.1089/hum.1994.5.4-501

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  19 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

2.  Directed evolution of adeno-associated virus to an infectious respiratory virus.

Authors:  Katherine J D A Excoffon; James T Koerber; David D Dickey; Matthew Murtha; Shaf Keshavjee; Brian K Kaspar; Joseph Zabner; David V Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 3.  Gene therapy for cystic fibrosis: challenges and future directions.

Authors:  J M Wilson
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

Authors:  N Mittereder; K L March; B C Trapnell
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

Review 6.  GUCY2C-targeted cancer immunotherapy: past, present and future.

Authors:  Adam E Snook; Michael S Magee; Scott A Waldman
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

Review 7.  Respiratory medicine.

Authors:  R M du Bois
Journal:  BMJ       Date:  1995-06-17

8.  Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia.

Authors:  D F Morrison; D L Foss; M P Murtaugh
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

9.  Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis.

Authors:  Y Zhang; B Doranz; J R Yankaskas; J F Engelhardt
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

10.  Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes.

Authors:  L Zhang; D Wang; H Fischer; P D Fan; J H Widdicombe; Y W Kan; J Y Dong
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.